↓ Skip to main content

Psychotropic medication use in adolescents with intellectual disability living in the community

Overview of attention for article published in Pharmacoepidemiology & Drug Safety, August 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
63 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Psychotropic medication use in adolescents with intellectual disability living in the community
Published in
Pharmacoepidemiology & Drug Safety, August 2013
DOI 10.1002/pds.3484
Pubmed ID
Authors

Tan Doan, Robert Ware, Lyn McPherson, Kate van Dooren, Christopher Bain, Suzanne Carrington, Stewart Einfeld, Bruce Tonge, Nicholas Lennox

Abstract

Information on the use of psychotropic medications in adolescents with intellectual disability is scant. Such information can guide interventions to improve psychotropic medication use in this population. We investigated the prevalence of, and factors associated with, psychotropic medication use in adolescents with intellectual disability in Australia who live in the community.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 2%
Unknown 62 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 21%
Researcher 11 17%
Student > Ph. D. Student 6 10%
Student > Bachelor 4 6%
Student > Doctoral Student 4 6%
Other 10 16%
Unknown 15 24%
Readers by discipline Count As %
Medicine and Dentistry 16 25%
Nursing and Health Professions 9 14%
Psychology 7 11%
Social Sciences 6 10%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 4 6%
Unknown 18 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2013.
All research outputs
#20,739,552
of 25,477,125 outputs
Outputs from Pharmacoepidemiology & Drug Safety
#1,683
of 2,177 outputs
Outputs of similar age
#159,107
of 209,200 outputs
Outputs of similar age from Pharmacoepidemiology & Drug Safety
#27
of 43 outputs
Altmetric has tracked 25,477,125 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,177 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one is in the 5th percentile – i.e., 5% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,200 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.